Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. (2018)

First Author: Bahig H
Attributed to:  Development of MRI-guided radiation therapy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 30386824

Publication URI:

Type: Journal Article/Review

Volume: 13

Parent Publication: Clinical and translational radiation oncology

ISSN: 2405-6308